ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,592, issued on Jan. 13, was assigned to UNIVERSITE DE LILLE (Lillie, France), INSTITUT PASTEUR DE LILLE (Lillie, France) and INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (Paris).

"ERAP inhibitors" was invented by Rebecca Deprez Poulain (Lille, France), Ronan Gealageas (Mauges-sur-Loire, France), Virgyl Camberlein (Dunkirk, France), Charlotte Tabey Fleau (Villeneuve d'Ascq, France), Valentin Guillaume (Faches-Thumesnil, France), Damien Bosc (Haubourdin, France), Benoit Deprez (Lille, France) and Pierre Sierocki (Mouvaux, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to novel compounds of formula (I)...